Adia Nutrition, Inc. (ADIA)

Market Cap	20.09M +4,014.6%
Revenue (ttm)	6.38K -98.1%
Net Income	-181.07K
EPS	-0.00
Shares Out	94.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10
Average Volume	38,132
Open	0.2050
Previous Close	0.2128
Day's Range	0.2050 - 0.2148
52-Week Range	0.0177 - 0.2777
Beta	-10.57
RSI	56.14
Earnings Date	n/a

About Adia Nutrition

Adia Nutrition, Inc. offers medical treatments and nutritional supplements. It operates in three segments: Biolete, Adia Med, and Adia Labs. The company provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients. It also operates Adia Med, a clinic to perform stem cell treatments, and Adia Labs, which procures and sells stem cell products to outside clinics or Adia Med. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer ...

• Industry: Shell Companies
• Sector: Financials
• Founded: 1999
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: ADIA